| 1 |
Kelly Abuelsaad |
IBM |
15 |
| 2 |
Shu-Jen Han |
IBM |
13 |
| 2 |
Wilfried E. Haensch |
IBM |
13 |
| #4 |
Jin Cai |
IBM |
12 |
| #5 |
Tamer E. Abuelsaad |
IBM |
10 |
| #6 |
John F. Bulzacchelli |
IBM |
7 |
| #7 |
Matthias Steffen |
IBM |
6 |
| #7 |
Philip Heidelberger |
IBM |
6 |
| #7 |
Jude A. Rivers |
IBM |
6 |
| #10 |
Rodric Rabbah |
IBM |
5 |
| #11 |
David B. Mitzi |
IBM |
4 |
| #11 |
Rachel M. Lind |
Evolved By Nature |
4 |
| #13 |
Ekaterina M. Ambroladze |
IBM |
3 |
| #13 |
Frank Pape |
Google |
3 |
| #13 |
Adam M. Pyzyna |
IBM |
3 |
| #13 |
Wilfried Haensch |
IBM |
3 |
| #13 |
Rakesh Mohan |
IBM |
3 |
| #13 |
Bernard V. Brezzo |
IBM |
3 |
| #13 |
Warren Groner |
Iris International |
3 |
| #20 |
Ricardo A. Donaton |
IBM |
2 |
| #20 |
Michel H. T. Hack |
— |
2 |
| #20 |
Jeff Shimizu |
Medimetrics Personalized Drug Delivery |
2 |
| #20 |
Min Wang |
IBM |
2 |
| #20 |
Bryan S. Rosenburg |
IBM |
2 |
| #20 |
Jiri Navratil |
IBM |
2 |
| #20 |
Asser Nasreldin Tantawi |
IBM |
2 |
| #20 |
James E. Christensen |
IBM |
2 |
| #20 |
Joel L. Wolf |
IBM |
2 |
| #20 |
James D. Warnock |
IBM |
2 |
| #20 |
Katsunori Onishi |
IBM |
2 |
| #31 |
Mitchel Stein |
Ascensia Diabetes Care Holdings Ag |
1 |
| #31 |
Brenda Dietrich |
IBM |
1 |
| #31 |
Sarah J. Kasperbauer |
Acorda Therapeutics |
1 |
| #31 |
Chao-Kun Hu |
IBM |
1 |
| #31 |
Li-Hsien Wang |
Regeneron Pharmaceuticals |
1 |
| #31 |
Phlip Heidelberger |
Globalfoundries |
1 |
| #31 |
Ronald Gary Feuchs |
— |
1 |
| #31 |
Luke Batchelder |
Convey Technology |
1 |
| #31 |
Anthony L. Cioffi |
— |
1 |
| #31 |
Mohammad Haris Baig |
Apple |
1 |
| #31 |
Jason Brazzillo |
Zealand Pharma A/S |
1 |
| #31 |
Ibrahim M. Elfadel |
IBM |
1 |
| #31 |
Hongwen Yan |
IBM |
1 |
| #31 |
Joanna Rosner |
IBM |
1 |
| #31 |
Donna L. Gresh |
IBM |
1 |
| #31 |
George Liang-Tai Chiu |
IBM |
1 |
| #31 |
Robert Sultan |
Futurewei Technologies |
1 |
| #31 |
Geza Medveczky |
New York University |
1 |
| #31 |
Justin G. Manweiler |
IBM |
1 |
| #31 |
Thomas E. Chefalas |
IBM |
1 |